NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Multiple Myeloma
    Multiple Myeloma
    medium
    microscope Pathology

    A 62-year-old man with newly diagnosed multiple myeloma is being counseled about his disease. Which of the following is NOT a typical feature of multiple myeloma?

    A. Lytic bone lesions due to increased osteoclast activity mediated by RANKL
    B. Hypercalcemia from increased intestinal absorption of calcium via active vitamin D synthesis by myeloma cells
    C. Anemia primarily due to marrow infiltration by plasma cells and EPO suppression
    D. Hypercalcemia from osteoclastic bone resorption and increased renal reabsorption of calcium

    Explanation

    Calcium Metabolism in Multiple Myeloma

    Key Point
    Hypercalcemia in myeloma arises from two mechanisms: (1) osteoclastic bone resorption driven by RANKL and other cytokines, and (2) impaired renal excretion due to light-chain nephropathy. Myeloma cells do NOT produce calcitriol (active vitamin D) — this is a feature of granulomatous diseases (sarcoidosis, tuberculosis) and lymphomas, not myeloma.
    Mechanisms of Hypercalcemia in Myeloma
    Table
    MechanismPathophysiologyFrequency
    Osteoclastic resorptionRANKL, TNF-α, IL-6 from myeloma cells stimulate osteoclastsMost common
    Impaired renal excretionLight-chain cast nephropathy reduces GFR and calcium clearanceCommon
    PTHrP secretionRare in myeloma (more common in solid tumors)Uncommon
    Calcitriol productionNOT a feature of myelomaDoes not occur
    High-YieldNEET PG
    The distinction between myeloma-induced and granulomatous hypercalcemia is testable. Myeloma causes hypercalcemia through bone resorption and renal dysfunction, NOT through vitamin D activation.
    Clinical Pearl
    When evaluating hypercalcemia in a myeloma patient, check 1,25-dihydroxyvitamin D levels — they should be suppressed (low), not elevated. An elevated level suggests an alternative diagnosis (sarcoidosis, lymphoma).
    Why Option 3 is Correct

    Myeloma cells lack the enzymatic machinery (1α-hydroxylase) to convert 25-hydroxyvitamin D to the active 1,25-dihydroxyvitamin D form. This is a defining feature of granulomatous and lymphoproliferative diseases, not myeloma.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →